What is a systematic review, and why does it matter for shockwave therapy?

A systematic review is a rigorous analysis that identifies, evaluates, and synthesizes all available clinical trials on a specific question. When a systematic review concludes that a treatment works, that finding carries more weight than any single study because it accounts for the full body of evidence, including studies with negative or mixed results.

Do systematic reviews agree that shockwave therapy works?

For chronic plantar fasciitis and calcific shoulder tendinitis, systematic reviews consistently find ESWT superior to placebo. For tennis elbow, results are more mixed, with some reviews finding significant benefit and others finding only modest effects. The level of agreement depends heavily on the specific condition and how 'success' is defined.

Why do some systematic reviews reach different conclusions about the same treatment?

Reviews can reach different conclusions because they include different studies (based on inclusion criteria), analyze different outcome measures, or weight study quality differently. Differences in the shockwave devices used (focused vs. radial), patient populations, and follow-up durations across included studies also contribute to heterogeneity in findings.

What Do Systematic Reviews Say About Shockwave Therapy?

If you have been researching shockwave therapy, you have probably encountered conflicting claims. One clinic says 90% success rates. A skeptical article says the evidence is weak. Individual studies seem to support both positions depending on which one you read. So how do you sort through the noise?

The answer is systematic reviews and meta-analyses – studies that analyze all available clinical trials on a question and synthesize the overall evidence. They sit at the top of the evidence hierarchy, and for ESWT, they tell a more nuanced story than either the enthusiasts or the skeptics suggest.

Why Systematic Reviews Sit at the Top

Not all medical evidence is created equal. The hierarchy of evidence, from weakest to strongest, generally runs:

Expert opinion and case reports
Case series and observational studies
Individual randomized controlled trials (RCTs)
Systematic reviews and meta-analyses of multiple RCTs

A single RCT can produce misleading results due to small sample size, flawed methodology, or patient selection bias. A systematic review pools data from multiple trials, identifies patterns that no single study can reveal, and assesses the overall quality of the evidence.

When patients ask whether shockwave therapy “really works,” the most honest answer comes from these pooled analyses rather than from any individual study – whether that study is positive or negative.

What the Major Reviews Find, by Condition

Here is what the highest-level evidence says for the conditions most commonly treated with ESWT.

Plantar Fasciitis

The largest body of systematic review evidence exists for ESWT and chronic plantar fasciitis. A Cochrane review analyzed 11 trials with over 1,300 patients and found that ESWT produced statistically significant pain reduction compared to sham treatment at 12 weeks and beyond. The improvement was modest – roughly 1-2 points on a 10-point pain scale – but consistent across studies (Thomson et al., 2005, Cochrane Database of Systematic Reviews).

More recent meta-analyses including studies published after the Cochrane review have found somewhat larger effect sizes, particularly for focused ESWT and for patients who had failed at least 6 months of conservative treatment. The consensus across reviews: ESWT works for chronic plantar fasciitis, especially in patients who have not responded to first-line treatments.

For detailed data on response rates, see our article on shockwave therapy success rates by condition.

Calcific Shoulder Tendinitis

This may be ESWT’s clearest evidence win. Multiple systematic reviews find that focused ESWT significantly improves pain and shoulder function and promotes calcium deposit resorption. A meta-analysis of 8 RCTs found calcium resorption rates of 70-85% with ESWT versus 15-25% with sham treatment – a large, clinically significant difference (Ioppolo et al., 2013, Archives of Physical Medicine and Rehabilitation).

The evidence is strong enough that several international guidelines recommend ESWT as a first-line treatment for calcific shoulder tendinitis before considering surgical removal of calcium deposits.

Tennis Elbow (Lateral Epicondylitis)

Here the evidence is more contested. Early systematic reviews found limited or no benefit for ESWT over placebo. However, these reviews often included studies using low-energy protocols that subsequent research suggests may be subtherapeutic. More recent meta-analyses including higher-energy protocols and longer follow-up periods have found statistically significant benefits for ESWT over sham (Yao et al., 2020, Orthopaedic Journal of Sports Medicine).

The discrepancy between earlier and later reviews highlights a key challenge: the “dose” of shockwave therapy matters, and early studies may not have used effective treatment parameters.

Achilles Tendinopathy

Systematic reviews generally support ESWT for chronic Achilles tendinopathy, though with more modest effect sizes than for calcific tendinitis. A 2020 meta-analysis of 6 RCTs found significant improvement in pain and function scores compared to sham, with a pooled effect size in the moderate range. As with tennis elbow, focused ESWT showed somewhat larger effects than radial in subgroup analyses.

Trigger Points and Myofascial Pain

Evidence for ESWT and myofascial trigger points is growing but less mature. A 2019 systematic review found that radial ESWT reduced pain intensity and improved pressure pain threshold compared to sham, but the number of included trials was small and study quality was variable. More and better trials are needed before definitive conclusions can be drawn.

Where Reviews Agree

Despite differences in specific conclusions, several findings are consistent across the systematic review literature:

ESWT is better than placebo for most chronic tendinopathies when adequate energy levels are used
Benefits take time to materialize – studies with follow-up of 3+ months show larger effects than those measuring outcomes at 4-6 weeks
Patient selection matters – ESWT works best for chronic conditions (3-6+ months) that have failed conservative treatment
ESWT is safe – serious adverse events are rare across all reviews; common side effects are mild and transient (redness, bruising, temporary pain increase)

Where Reviews Disagree

The areas of disagreement are equally important:

Optimal protocols. There is no consensus on the ideal number of sessions, energy level, impulse count, or session spacing. This heterogeneity in clinical protocols is one of the biggest sources of variability in study outcomes and review conclusions.

Focused vs. radial. Some reviews find focused ESWT produces larger effects; others find comparable results. The answer may depend on the condition, but the evidence does not yet provide definitive guidance for every indication.

Dose-response relationships. Whether higher energy always means better outcomes is unclear. Some evidence suggests a therapeutic window – too little energy is ineffective, but very high energy may not add benefit and increases discomfort.

Publication bias. Systematic reviews themselves can be affected by publication bias (positive studies are more likely to be published). Funnel plot analyses in some ESWT meta-analyses suggest this may be a factor, potentially inflating reported effect sizes.

Read more about conditions treated with shockwave therapy to explore the evidence for your specific situation.

How to Interpret These Findings

For patients evaluating whether shockwave therapy is worth trying, the systematic review evidence supports several practical conclusions:

If you have chronic plantar fasciitis or calcific shoulder tendinitis and conservative treatments have failed, ESWT has strong evidence behind it
If you have chronic tennis elbow or Achilles tendinopathy, evidence is positive but more moderate
Expect improvement rather than a cure – systematic reviews consistently show meaningful but partial pain reduction
Give the treatment time to work – benefit accumulates over 3-6 months, not days

The Bottom Line

Systematic reviews – the highest tier of clinical evidence – support shockwave therapy as an effective treatment for several chronic musculoskeletal conditions, most convincingly for calcific shoulder tendinitis and chronic plantar fasciitis. The evidence is positive but more nuanced for tennis elbow and Achilles tendinopathy. Areas of ongoing uncertainty include optimal treatment protocols, device type selection, and long-term outcomes beyond 12 months.

When evaluating shockwave therapy for your condition, look beyond individual studies and clinic marketing. Ask your provider what the pooled evidence says, and set expectations accordingly.

Explore our complete guide to conditions treated with shockwave therapy to see whether the evidence supports ESWT for your specific situation.

References

Thomson CE, Crawford F, Murray GD. The effectiveness of extra corporeal shock wave therapy for plantar heel pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2005;6:19. PubMed
Ioppolo F, Tattoli M, Di Sante L, et al. Clinical improvement and resorption of calcifications in calcific tendinitis of the shoulder after shock wave therapy at 6 months’ follow-up: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94(9):1699-1706. PubMed
Yao G, Chen J, Duan Y, Chen X. Efficacy of extracorporeal shock wave therapy for lateral epicondylitis: a systematic review and meta-analysis. Biomed Res Int. 2020;2020:2064781. PubMed

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Shockwave therapy outcomes vary by individual and condition. Consult a qualified healthcare provider to determine if shockwave therapy is appropriate for your situation.